KaminetskyJ, RudikoffD. New-onset vitiligo following mRNA-1273 (Moderna) COVID-19 vaccination. Clin Case Rep, 2021; 9(9):e04865. doi:10.1002/ccr3.4865.
2.
CorbedduM, DiociaiutiA, VinciMR, SantoroA, CamisaV, ZaffinaS, El HachemM. Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 vaccine: an Italian single-centre case series. J Eur Acad Dermatol Venereol, 2021; 35(8):e483–e485. doi: 10.1111/jdv.17268.
3.
DahirAM, ThomsenSF. Comorbidities in vitiligo: comprehensive review. Int J Dermatol, 2018; 57(10):1157–1164. doi: 10.1111/ijd.14055.
4.
DasD, AkhtarS, KurraS, GuptaS, SharmaA. Emerging role of immune cell network in autoimmune skin disorders: an update on pemphigus, vitiligo and psoriasis. Cytokine Growth Factor Rev, 2019; 45:35–44. doi: 10.1016/j.cytogfr.2019.01.001.
5.
WerfelT, BiedermannT. Current novel approaches in systemic therapy of atopic dermatitis: specific inhibition of cutaneous TH2 polarized inflammation and itch. Curr Opin Allergy Clin Immunol, 2015; 15(5):446–52. doi: 10.1097/ACI.0000000000000199.